Oncolytics Biotech (ONCY) Posts Q1 Loss of 6c/Share

Oncolytics Biotech (NASDAQ: ONCY) reported Q1 EPS of ($0.06), $0.01 better than the analyst estimate of ($0.07).

For earnings history and earnings-related data on Oncolytics Biotech (ONCY) click here.

You May Also Be Interested In

• JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
• Hertz cuts guidance, announces notes and stock offerings, shares sink
• TD Cowen cuts Flowserve to Hold, flags guidance reset risk amid Mideast woes